You may also like
ABIOMED Issues Update on AbioCor Heart Program Status; Clinical Trial To Begin Soon
ABIOMED, Inc. (NASDAQ:ABMD) announced today that while device and team readiness have been demonstrated for several weeks, the first human implantation of […]
Successful Intraoperative Reversal of Heparin With Factor VII in a Patient With Protamine Reaction
We report the case of a patient who developed intractable bleeding after a severe protamine reaction following emergency repair of type A aortic dissection and was successfully treated with factor VII.
Hyperlactatemia during Cardiopulmonary Bypass: Risk Factors and Impact on Surgical Results with a Focus on the Long-Term Outcome
Correction of risk factors for hyperlactatemia, together with prompt detection and correction of this condition, may control complications and improve outcome.